May 4, 2022

Five Doses of COVID-19 Vaccine Recommended for Cancer Patients

There have been many questions from cancer patients regarding how many COVID-19 vaccines they should receive—and there is finally a conclusive answer. Pharmacists can share the latest guidance from the National Comprehensive Cancer Network, which recommends a three-dose primary mRNA vaccination series followed by two booster doses—for a total of five doses—to be considered up-to-date on immunization. Read more.


Undertreated Hypothyroid Patients Have Worse Hospital Outcomes

Taking the correct amount of thyroid hormone replacement is especially important for patients with hypothyroidism who end up hospitalized, according to a new study in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism. Find out the risks of those patients being undertreated, including longer hospital stays and elevated readmission rates.

Androgen Suppression Trial for COVID-19 Halted for Futility

While it seemed promising that using androgen-suppressing drugs approved for prostate cancer might also help protect men against severe COVID-19, a trial testing the theory had to be stopped for futility. Even though SARS-CoV-2 entry requires the TMPRSS2 cell-surface protease, temporary androgen suppression induced by degarelix did not improve the clinical outcomes of COVID-19 inpatients. Read more.


Cost of Treating Warts Lowered With Topical Therapies

Pharmacists do not fill enough prescriptions to treat cutaneous and anogenital warts, according to a new study, which suggests that prescription products might be the most cost-effective treatments. The authors reported that the complaints lead to millions of office visits and average costs per year of about $846 million for cutaneous warts and $127 million for anogenital warts, largely because of lesional destruction procedures. Read more.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -